Journal of Medical Economics
Volume 23, 2020 - Issue 6
Open access
2,371
Views
2
CrossRef citations to date
0
Altmetric
Rheumatology
Cost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic review
Matthew SussmanModeling and Evidence, Boston Health Economics, LLC, Boston, MA, USA; Correspondence[email protected]
, Charles TaoModeling and Evidence, Boston Health Economics, LLC, Boston, MA, USA;
, Pankaj PatelHealth Economics and Outcomes Research, AbbVie, North Chicago, IL, USA
, Namita TundiaHealth Economics and Outcomes Research, AbbVie, North Chicago, IL, USA
, Jerry ClewellHealth Economics and Outcomes Research, AbbVie, North Chicago, IL, USA
& Joseph MenzinModeling and Evidence, Boston Health Economics, LLC, Boston, MA, USA;
Pages 610-623
|
Received 16 Oct 2019, Accepted 17 Jan 2020, Published online: 07 Feb 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.